SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " Guard " 1,812 found 🔀 AI-powered Shuffle
Lawyers offer 7 boxes to check before hiring your next regulatory compliance officer
Hospitals are not the only healthcare entities competing over a limited pool of qualified compliance officers. Payers, vendors and others are in the race too. But hospitals and health systems may have the most to lose if they let down their guard on adherence to regulatory rules.
Palantir Just Issued a Warning to Business Leaders About AI: Guard This 1 Thing Like 'Treasure'
Palantir also warned about tokenmaxxing and a sense of 'false progress.'
Cavs sign rookie Meleek Thomas to a four-year deal
The Cleveland Cavaliers have signed Meleek Thomas to a four-year, $9.3 million deal. Thomas was selected 34th overall by the Cavs last week in the 2026 NBA Draft. Thomas played 37 games with Arkansas last year as a freshman. He averaged 15.7 points and 3.8 rebounds as a 6’3” sharpshooting combo-guard. The Cavs are excited […]
Brand New The Blood of Dawnwalker Gameplay Showcases Coen’s Investigation Skills and a Boss Battle Against the Eerie Forgotten Guardian
See Coen's investigation and fighting skills on full display in this quest gameplay from The Blood of Dawnwalker.
Just in: Ex-Science minister Uche Nnaji arrested at Abuja Airport
Former Minister of Science and Technology, Uche Nnaji, was on Wednesday arrested at the Nnamdi Azikiwe International Airport, Abuja, shortly after arriving from Enugu aboard a chartered flight.
Cleveland Guardians’ Rookie Kahlil Watson Flashing Major League Tools
Cleveland Guardians rookie outfielder Kahlil Watson has shown power, speed, a good hit tool, and solid defense after his graduation to the major league club
Guardians rookie Cooper Ingle tosses ball into stands early after losing outs count in loss to Rangers: 'I feel terrible'
New BioShocking attack manipulates AI browser into data theft
A new prompt injection attack dubbed "BioShocking" could trick AI-powered browsers into treating real-world risky actions as part of a fictional scenario, causing them to ignore any safety guardrails.
The Guardians 2026 Trade Deadline Manifesto
Surveying the landscape a month ahead of the deadline
Warriors backup point guard declines 2026-27 player option
De'Anthony Melton has declined his player option for next season after averaging a career high in points last year.
Atlanta Dream Announce Signing of WNBA Champion Guard Jaylyn Sherrod
The Dream used a player development spot to add guard depth.
ESPN Analyst Chiney Ogwumike Defends Alyssa Thomas' Behavior
ESPN WNBA analyst Chiney Ogwumike is coming to the defense of Phoenix Mercury forward Alyssa Thomas. Thomas was suspended for one game and fined for her hits on Indiana Fever guard Caitlin Clark last week. Thomas was caught hitting Clark in the groin and the neck, though she wasn't called for a ...
Jalen Brunson receives praise from Knicks fans for offseason work
Jalen Brunson is wasting no time keeping himself in shape this offseason. He led the New York Knicks to the 2026 NBA championship on June 13, and the superstar guard is already working out 16 days later. A video of…
Nine-year NBA veteran indicted on federal sports gambling charges
Veteran NBA shooting guard Malik Beasley has been indicted on federal charges for gambling related to a sports betting scheme, such as point shaving and prop bets, his attorney Steve Haney told ESPN. on June 29. According to Shams Charania,…
Ahead of the MLB trade deadline, here’s where the Guardians stand
The Guardians are among the best teams in a weak American League. This is the time for them to capitalize on their situation.
What was it like to guard Shaq in college? ‘Glad I got him as a freshman’
Southern Miss forward Clarence Weatherspoon, who went on to play in the NBA, was the first college player to guard Shaq in a game.
Benchmark Scores Don’t Break. Clinical Reality Does. The Health AI Readiness Illusion.
Nature Medicine's frontier AI evaluation exposes a dangerous gap: models acing medical benchmarks collapse under adversarial pressure, and the FDA has no…
'Nobody likes you': Argument between former teammates Josh Naylor and Austin Hedges gets personal in Mariners-Guardians
Evans Has Reportedly Been 'Unguardable' at 49ers Practice
The future Hall of Famer is stunning teammates in San Francisco, dominating red zone drills and exceeding high expectations as he anchors a loaded arsenal for Brock Purdy.
Lagos school emerges winner of 10th Edition of Tolaram Science Challenge
By Efe Onodjae Iwerekun Community Senior High School, Ibeju-Lekki, has emerged the winner of the 10th edition of Tolaram Science Challenge (TSC), marking their third consecutive win. The school triumphed over Magbon-Alade Senior Grammar School in a keenly contested grand finale of the competition. The Tolaram Science Challenge, sponsored by Lagos Free Zone, is an annual […]
Cleveland Takes Series from Seattle in Sunday Victory
Seattle Mariners 5 - Cleveland Guardians 6
Arkansas Department of Health urges caution during extreme heat
Now that it is officially summer, state health officials want to make sure you're on guard against the extreme heat.
Hornets send Miles Bridges to Phoenix Suns, AP source says
Guard Grayson Allen and forward Royce O’Neale would be coming to Charlotte, according to a person familiar with the deal.
Letters to Sports: Is Austin Reaves worth the $185-million deal?
L.A. Times readers weigh in on the re-signing of Lakers guard Austin Reaves, as well as the Dodgers' hits and misses.
Guardians score, lineups vs Seattle Mariners at Progressive FIeld
The short-handed Guardians look to find some offense against the Mariners at Progressive Field. Follow along here for live updates.
Making Our Own Luck
We are cross-posting a piece that former NIH official Kris Willis wrote for Macroscience. Kris is now the President and Founder of the Woodley Park Institute, for which I’m a board member. Picking winners or hedging bets? Federal science agencies have long wrestled with the question of how to ensure their billions of dollars of grants and contracts result in maximum benefits for Americans. On the surface, it might seem that a goal-oriented, interventionist style of management would be the best policy: prioritize our most pressing problems and distribute funding accordingly.This top-down strategy creates a unique hazard, though: bad choices can send resources in the wrong direction, resulting in slow progress that impedes the delivery of tangible benefits to citizens. Moreover, if decision makers pursue an applied advance when the underlying scientific principles remain poorly understood, they risk costly failures and a loss of support for the research enterprise at large. Examples include Nixon’s 1971 War on Cancer, undertaken on the premise that a cure could be achieved in less than a decade, the drive to build an operational commercial fusion plant by the mid-1990s, and the National Plan to Address Alzheimer’s Disease, which failed to produce the effective treatments and prevention strategies promised by 2025. The contrasting laissez-faire approach is to hedge your bets. If the path to an advance is impossible to predict, then the wisest choice might be to distribute funding to as widely as possible. The main risk of this strategy is that spreading funding thinly may limit the resources available to the most promising research, resulting in the same negative outcomes as the interventionist approach: limited support for the most promising topics, slow progress, and delayed returns. In reality, at science agencies like the National Science Foundation and National Institutes of Health, program managers navigate between these two extremes, setting some funds aside to target high-priority areas and using the rest to cover the widest possible range of meritorious proposals. This middle path seems like the most rational way to proceed, but it still requires making choices. How much should be set aside for high priority topics? What should those topics be? How should we define merit? Expert opinion can provide a helpful guide, but leading experts can have remarkably different opinions about what matters and what should be prioritized. Moreover, experts and administrators alike can be risk averse, giving an edge to high-profile, well-established concepts. What’s really needed is a data-driven framework to help guide decision-making, one that doesn’t simply repackage prestige or incumbency. Recognizing breakthroughs years in advance Many breakthroughs fail to attract funding or recognition at the earliest stages of development. Katalin Karikó, for example, spent years struggling to win grants for work on mRNA that would eventually win her and Drew Weissman a Nobel Prize. Similar stories can be told about Jim Allison’s groundbreaking studies leading to the development of cancer immunotherapy, Stan Pruisner’s demonstration that prions can self-replicate without DNA, or Robin Warren and Barry Marshall’s proof that Helicobacter pylori, not stress, causes ulcers. Yet at some point, the scientific community recognizes and responds to transformative breakthroughs like these. How does that change happen? And what if science funders could identify the areas that are on the cusp of a breakthrough? Those questions led my collaborators and me to study how scientists responded to past breakthroughs. Based on patterns in that data, we developed a means of predicting future breakthroughs, using biomedicine as a proof of concept. It’s worth taking a moment to describe how our approach works. Briefly, our prediction process begins by grouping the 18 million or so peer-reviewed papers in PubMed, the authoritative database of biomedical research, into roughly 50,000 unique topics. A small subset of these topics are so widely acclaimed as breakthroughs that they have been recognized with a major prize like a Nobel or a Lasker Award. We theorized that studying the development of these outliers over time, especially before they gained acclaim, was the key to identifying future instances of them. After defining topics, we chose 21 representative breakthroughs and asked what they looked like before they won prestigious prizes. To answer that question, we re-ran our topic-mapping algorithm repeatedly, winding back the clock one year each time, stringing together the years to follow the progress of each field as it grew and advanced. We found that in each case, the years leading up to a discovery followed a pattern: a burst of papers on a new, rapidly evolving topic, many of which quickly became influential. These characteristics—the percent of papers that are new, the percentage of papers that are brought in from other topics, and the influence of each individual paper—can all be measured separately for any given topic. Together, they act as a predictive signal that is detectable an average of five years before a transformative discovery is made, and up to thirty years before the discovery receives a major prize. Scanning the current research landscape for topics that display this signal allows us to predict what work will likely produce a future breakthrough. Each year we analyzed includes four or five signals, a number that appears to have remained constant across a twenty year time frame. In their classic work on the sociology of science, Bruno Latour and Steve Woolgar established that the desire to participate in a major discovery is an important motivator for scientists as they consider whether they should take up (or abandon) a research problem. Although further work is needed, the simplest explanation for our results is that this behavior is widespread enough to detect at scale. A foundational advance, or something like it, draws the attention of scientists and causes them to change the direction of their research. They vote with their feet, staking their own reputation and careers by publishing on and citing the new idea. That upswell of interest is the foundation of our breakthrough signal. What kind of research does our model identify as a breakthrough? After building a model based on the patterns in our 21 preselected breakthroughs, we tested it by identifying all early signals of discovery from 1994 through 1997. Of the 18 signals we found in that time period, 17 can be traced forward in time to a breakthrough. Examples include super-resolution fluorescence microscopy (see the image above), the directed evolution of proteins and enzymes (Chemistry Nobel, 2018), and sequencing the human genome (National Medal of Science, 2008). The discovery of the role of leptin signaling in obesity is a particularly interesting case study. Around 1950, scientists noticed the existence of a type of lab mouse that suffered from a unique inherited form of obesity. When given the freedom to choose their own diet, these mice ate more than normal and preferred food that was high in fat. Researchers had few clues as to why the animals overate; early experiments pointed to the existence of a soluble ob factor found circulating in the bloodstream that regulated appetite, but its identity was unknown. In 1994, Jeffrey Friedman and colleagues identified and sequenced the ob gene, noting that the protein it encoded appeared to fit the profile of a circulating factor. A year later, a trio of high-profile publications demonstrated that ob was a hormone that regulated body weight and fat deposition by regulating appetite. One of these was co-authored by Friedman, who christened it leptin from the ancient Greek word for thin. Using our model, the data from 1996 make it clear this advance would become a breakthrough. Scientists had flocked to study the biology of the new hormone, generating the flurry of new papers and citations required to produce a signal. One of these demonstrated that serum leptin concentrations reflected the amount of adipose tissue in the human body, providing clinical validation of the earlier mouse studies. Before the identification of leptin, scientists were unable to point to a specific molecule that controlled appetite and adiposity, so that it was impossible to rule out non-physiological causes of obesity; its characterization fundamentally changed our concept of weight gain. In 2010, Friedman and fellow pioneer Douglas Coleman were awarded a Lasker for the discovery. Our work also identifies breakthroughs in clinical practice and behavioral and social sciences, even though these areas are less likely to draw the attention of major prize committees. One example that falls into this category is the introduction of endovascular aneurysm repair, a minimally invasive surgical procedure for the treatment of abdominal aortic aneurysm, a leading cause of death among Americans over the age of 65. Relative to the previous standard of care, it reduces in-hospital mortality by almost four-fold. In 2017, Timothy Chuter received the American College of Surgeons’ prestigious Jacobsen Innovation award for his multiple refinements to the technique. Another under-recognized breakthrough identified by our model is the development of standardized survey instruments to assess the quality of life for HIV+ patients. The antiretroviral cocktails introduced in the mid-1990s reduced AIDS mortality, but treatment came with serious side effects. The new evaluations showed that patients whose disease progressed had worse physical functioning than Americans with other chronic diseases, while those who were asymptomatic maintained a health-related quality of life on par with the overall US population. This evidence made it possible for patients and activists to argue that even in the absence of a total cure, and in spite of the side effects, alleviation of symptoms was a worthwhile priority for clinicians. My colleagues and I have failed to identify any significant recognition for the physicians and health policy experts who pioneered this advance, although in 2016, researchers called for the World Health Organization to set targets for good health-related quality of life as part of its framework to end the AIDS pandemic. From forecasting to funding How should science funders use our predictions? Any serious discussion of what we should do with this new capability needs to begin with an understanding of its limitations. We can’t (and shouldn’t) invest all of our resources in the small number of topics predicted to produce breakthroughs. Innovative new fields are born from existing ones; they rarely arise de novo. If funders don’t maintain a diverse portfolio, the breakthroughs of tomorrow will have no antecedents. Think of this as eating the seed corn, or killing the goose that lays the golden egg. There are also multiple goals of funding beyond basic scientific discovery, including translating discoveries into clinical practice, developing new technologies, supporting economic development, and training new scientists. The investments needed to accomplish these goals are likely different from those required to support emerging breakthroughs. Finally, we must be aware that we may not capture every instance of a breakthrough. The concept is fuzzy, and not every significant discovery is recognized with a major award. Further, breakthroughs are rare, meaning that our dataset is, by necessity, small. This makes formal estimates of accuracy challenging. Although our overall success rate appears to be high, any one signal may turn out to be a false positive. We found one apparent example: the development of the third generation COX-2 inhibitors, Vioxx and Celebrex, which were much celebrated in the early 2000s as effective but non-addictive pain relievers, meets all the algorithmic criteria of a breakthrough. Five years after it received FDA approval, researchers demonstrated that Vioxx was associated with serious cardiovascular complications, and the manufacturer voluntarily pulled the drug from the market. Celebrex remains available, although like other NSAIDs, it carries an FDA warning for increased cardiovascular risk. Decision makers who were overly focused on the breakthrough potential of this research might have wasted substantial resources nurturing an area that ultimately proved to be a failure—but so would those who relied on expert opinion at the time. That said, the potential benefits of funding the next mRNA vaccine or cancer immunotherapy years earlier than we might have are large. When we can’t assume the outcome of an action, it’s worth conducting an experiment. Can targeted support for areas that are poised to produce a breakthrough increase the return on scientific investment without cannibalizing future advances? With the necessary administrative infrastructure in place, conducting this experiment would be straightforward. First, identify all the breakthrough signals between 2018 and 2023, select half at random, and commit to a decade of investment. For biomedicine, a six year window should yield about 30 topics with the potential to produce a breakthrough. Providing strong support to half of these might be accomplished for $300 million a year. That’s roughly half of the recent annual budget of the NIH Common Fund or around 20% of the fiscal year 2025 budget for ARPA-H. After five years, then again at ten, compare to see which group — the one that was actively managed, or the control — produced more breakthroughs, and on what timescale. Although we used biomedicine as an example, the same experiment could just as well be run for physics, materials science, or any other discipline. Any attempt to undertake such an experiment should keep three points top of mind. First, we can predict the topic of future breakthroughs, but the people and vision for how to move the work forward are still important. In practice, this means success requires active program managers with the expertise to develop the science and the authority to do so, including by recruiting investigators. Second, we would be wise to learn from the failures of past attempts to fund transformative research. High among these are funding modestly repackaged work, confusing the genuinely novel with the merely unfamiliar, and relying too much on incumbent investigators. All of these risks can be mitigated by thoroughly and intelligently integrating high quality data into portfolio management. Finally, we need to have patience. Even with strong funding support, producing a breakthrough takes time. If supporting breakthroughs is the best way to nurture the birth of new fields, we also need to accurately describe and properly manage the other two stages, so that we invest wisely throughout the productive lifetime of ideas and divest once they reach the point of diminishing returns. We would benefit from more study of all of these phases, especially the transition from one to another. More research could answer questions like: When does a breakthrough become an established field? How do the availability of funding, the size and characteristics of the available workforce, and the accumulation of evidence that disagrees with prevailing models affect a field’s decline? Exactly how do old ideas give birth to new ones, and can we speed up the process? The more we understand about the dynamics of scientific progress, the better we can maximize the odds that our curiosity leads to results. I’d call that finding a way to make our own luck.
Adidas’ NIL pipeline is producing NBA rookies who already know the business
Mikel Brown Jr. reached the NBA with a head start few rookies have. Long before being selected sixth overall by the Brooklyn Nets at Tuesday’s NBA Draft, the 20-year-old guard had been embedded in Adidas’ ecosystem through a name, image and likeness deal that began in high school. “By the time our athletes walk across […]
Bo McCalebb Inducted into the Allstate Sugar Bowl New Orleans Sports Hall of Fame
NEW ORLEANS — Former University of New Orleans All-American guard Bo McCalebb reiterated how much he loved his time on the Lakefront as he was inducted into the Allstate Sugar Bowl's New Orleans Sports Hall of Fame on Wednesday night.
LaMelo Ball traded to Minnesota Timberwolves: Hornets ship out All-Star point guard in stunning deal
Charlotte will receive Naz Reid and a swath of future picks in the trade
How should European scientists respond to the US AI kill switch?
Earlier in June, Europe’s worst fears of technological dependence were confirmed when the White House ordered the AI firm Anthropic to stop non-US citizens using its leading models. This kill-switch moment crystalised anxieties in Brussels that the continent, lagging the US on the creation of leading-edge AI models, is now a technological of vassal of Washington. The shock has specific implications for European scientists and universities. Some governments are now worried that with AI being integrated into labs, Donald Trump now has his finger hovering over an off switch for European science. “Having restrictions on this tool, it can have an impact on our own research,” said France’s research minister, Philippe Baptiste, at the VivaTech conference in Paris on June 18.Baptiste, himself a former academic, said that colleagues in mathematics had recently warned him they were now cut off from leading-edge US models, risking their work. “This model is not available anymore now because of the US restriction, and for the first time this had an impact on mathematics,” a field where large language models (LLMs) are making a significant contribution, said Baptiste. So, should European scientists avoid relying on US models in the future? Or would this be a self-harming overreaction? And how is AI being used in science, anyway? What happened?On June 12, it emerged that Washington, citing cybersecurity concerns, had ordered Anthropic to stop non-US citizens using two models: Claude Mythos 5, and Claude Fable 5, a version of Mythos but with guardrails to prevent abuse. Anthropic said Washington’s concerns were overblown. But forced to follow the order, yet with no way to check who was using the models, the company suddenly shut down access for everyone, US citizens included. There’s still no agreement on how to restore broad access. But last week, Bloomberg reported that select US companies, and the US government, still had access to Mythos despite the ban, but the EU’s cybersecurity agency Enisa had been shut out. Class division of researchersIn the longer term, access outside the US should be restored, said Marcel Salathé, co-director of the AI centre at the Federal Polytechnic School of Lausanne (EPFL), because a permanent restriction would be financially ruinous to US AI firms. “Even Trump will eventually budge to economic pressure,” he said.However, US AI firms might end up operating rather like banks, doing due diligence on users of their leading-edge AI models, he went on.European scientists are unlikely to fall foul of such checks, he said. But having a Chinese postgraduate in their lab, or doing a type of research the US disapproved of, could potentially result in access being denied. “It will create a sort of class division of researchers,” he said. More than frontier modelsHowever, successfully deploying AI in science is about far more than just having access to leading LLMs such as Mythos.Instead, many science-specific tools, most famously Alphafold, which predicts protein folding structures, require “far less” computing power to train than frontier models, well within the capabilities of European supercomputers, according to a recent analysis by the Arq Foundation, a Brussel-based AI think tank. Instead, tools such as Alphafold are possible because certain fields, like protein folding, weather prediction or astronomy, have large, clean, standardised datasets that can be used to train predictive models. Rather than compute, “data is the central constraint for AI for science,” the report says. For example, a less powerful physics model trained on CERN’s data “will be more valuable than the best model without certain data,” said Bengüsu Özcan, author of the report. European advantage?Europe could therefore steal a march by using its scientific data and infrastructure to create models US digital giants cannot. “They might actually match or go even beyond what these big [US] companies are doing,” said Özcan.Indeed, some European start-ups hope to create automated testing labs to create the kind of standardised data that could speed up the discovery of new materials. Materials scientists say there’s currently too little data to train models. AI scientistsHowever, even if the bottleneck for AI in science is often data, rather than compute, being at the mercy of the US for LLM access could still become a problem for European scientists. A new class of “AI scientists” based on leading LLMs is also emerging, Özcan’s report says.Unlike domain-specific tools like Alphafold, these try to automate day-to-day scientific work, by providing an overarching tool that coordinates specific models to synthesise existing literature, generate hypotheses or run analysis of data. The problem for Europe, however, is that these tools are sometimes based on US leading models. Google Deepmind’s AI Co-Scientist, for example, is built on Google’s Gemini LLM. Systematic failureThese scientific automation tools are still in their early stages, and still exhibit “systematic failures on scientific tasks,” Özcan’s report says. One of the problems is that the messy, day-to-day process of scientific discovery is largely not documented, meaning LLMs don’t have a good source of data to learn how scientists actually work. Meanwhile, some tasks, such as literature synthesis, don’t typically require access to leading edge models.However, the performance of AI scientific assistants could improve as companies such as Google pour resources into developing them. Rely on US“Unfortunately, for scientific assistants, there is not much we can do right now except rely on US frontier AI,” said Antoine Bosselut, a natural language processing expert based at EPFL. Chinese-built open models, which can run on local computers, lessening the risk of a shutdown, are touted as one alternative to US dependence. There’s also Mistral, once seen as Europe’s main AI hope, but the Paris-based company has seen its recent models fall behind in performance. But the Chinese alternatives are generally not as capable as US frontier AI models, said Bosselut, unless paired with fiddly, custom tools that allows them to act as independent agents. “Most scientists do not have the time,” he said. Don’t jump ship yetAlthough the kill switch moment is seen a warning shot for European scientists, it doesn’t mean labs should abandon US AI tools immediately. “I do not think the right response is simply to abandon US-based models and systems under the banner of sovereignty or independence,” said Mattias Björnmalm, secretary general of the Cesaer university association. “That would be an overreaction.”Related articlesEuropean sovereignty in AI requires ‘ugly trade-offs,’ say experts Robotic lab start-up makes case for €500M EU-funded materials testing facilityAI in science: is it useful? Instead, European researchers need to ask themselves whether they’re becoming dependent on technology that could be turned off in Washington, said Özcan. “They might not see this today, but they should really start asking this question,” she said. European researchers need a plan B, said Salathé. “I would recommend to every researcher, very proactively explore alternatives.”Own toolsIn addition, Björnmalm and others want European research institutions to develop their own scientific AI tools.Instead of signing AI deals with US digital giants, European universities should be using this money to create their own models, which may end up being superior for research, said Sabine Leonelli, an expert on the use of AI in science at the Technical University of Munich. “Universities in Europe seem to be happy to sign commercial contracts with US companies on the assumption [their AI tools] are better,” she said. But US frontier LLMs are typically opaque, and have been developed without independent scientific input, she said. “This is not good enough for science.”Last year, Swiss researchers released Apertus, an LLM designed to be completely transparent, from its development methods to its training data. The idea is that this makes scientific tools built on top of the model far more reproducible than with closed, commercial alternatives.“Europe needs more of this: serious capacity-building that gives researchers, universities and companies credible options,” said Björnmalm.
Stubborn, arrogant, a genius: France’s De Gaulle epic shows up the tepidity of our politics
The man who led Free France during Nazi occupation was single-minded to the point of obstinacy. But he believed in his own power to make history, says Guardian Europe writer Alexander Hurst
Cavaliers named landing spot for ex-$206 million Lakers disaster
The Cleveland Cavaliers were linked to a former Los Angeles Lakers guard who struggled mightily with the franchise years ago.
Imagine trying to guard this 🤯
Imagine trying to guard this 🤯
Riot now lets you enable its anti-cheat when you want to
You’ll be able to turn on Vanguard just while you’re playing.
Report: Pacers Targeting Guard in Second Round of NBA Draft
The Indiana Pacers are reportedly targeting an intriguing guard in the second round of the 2026 NBA Draft.
Sixers add offensive firepower, draft guard Labaron Philon Jr. with 22nd pick
The Sixers selected Alabama product Labaron Philon Jr. with the 22nd pick in Tuesday night’s NBA draft.
Sophie Cunningham Posts Cryptic Video After Heated Altercation vs. Mercury
Indiana Fever guard Sophie Cunningham isn't afraid to get her hands dirty on the hardwood, that's for sure. During the fourth quarter of Monday night's Fever-Mercury game, DeWanna Bonner and Caitlin Clark were at the center of a pretty intense altercation. Both players were assessed technical fouls ...
TCU names NBA guard Desmond Bane as chief basketball officer
The former Horned Frog is getting involved with his collegiate program as a special advisor to coach Jamie Dixon.
Latest Injury Update on Guardians' Chase DeLauter
Chase DeLauter's return to the Cleveland Guardians' lineup might come sooner rather than later.
Keir Starmer has quit as prime minister – what will happen next in UK politics?
Britain will soon have its fifth prime minister in four years. The Guardian explains how we got here and what challenges await Starmer’s successor
Scientists stumped by bird that “shouldn’t exist”—rare discovery shocks experts - Futura-Sciences
A Bird That Defies the Rulebook In a typically peaceful backyard in Texas, birdwatchers were caught off guard when an unfamiliar bird swooped onto the scene. It baffled observers: clearly neither a typical blue jay nor a full-fledged green jay. What was it? The answer would turn out to be...
Timberwolves Surprisingly Linked to Bulls Guard Josh Giddey
The Timberwolves could go for an unexpected player.
Kaiser's use of secret AI scribes sparks mental health privacy fears
Mental health professionals at Kaiser are raising concerns about an artificial intelligence tool that records medical appointments, saying it should have more safeguards.
Isaiah Thomas facing pushback on Chris Paul-Spurs take
Isaiah Thomas sparked debates online with his big claim on Sunday. The two-time All-Star guard said that the San Antonio Spurs would’ve won the NBA championship if they still had Chris Paul. “The Point God” signed a one-year, $11 million…
Thunder reportedly trading Aaron Wiggins to Hawks for picks in deal that provides tax relief for OKC
The Oklahoma City have traded guard Aaron Wiggins to the Atlanta Hawks in exchange for two second-round picks, ESPN’s Shams Charania reports.
Scouting Stanford Guard Ebuka Okorie
Ebuka OkorieFrame: 6'2 185 lbsPosition: GuardTeam: Stanford Cardinals2026 Draft Age:Stats via https://www.sports-reference.com/cbb/players/ebuka-okorie-1.html Offense Ebuka Okorie emerged as one of the most productive freshman guards in the country and quickly transformed from an under-the-radar recruit into a legitimate NBA prospect. His offensive profile is built around dynamic scoring, relentless rim pressure, and advanced shot-making ability. Few
Bills news: Early preview of biggest training camp battles
Competition will be intense at left guard, cornerback opposite Christian Benford, No. 3 wide receiver and punter!
Guardians' Joey Cantillo: Leans on curveball
Guardians' Joey Cantillo: Leans on curveball
Lakers linked to Luka Doncic satisfying trade with Mavericks
The Los Angeles Lakers would appease their star point guard in a recent trade idea.
Suns reportedly re-signing Collin Gillespie to 4-year, $48 million deal following guard's breakout season
Gillespie, a former Villanova standout, went undrafted in 2022 and then played three straight seasons on two-way contracts. Now he has a long-term NBA contract.
Democratic states scramble to prevent potential Trump administration interference in their elections
Democratic-led states are racing to safeguard November’s midterm elections against potential interference from the Trump administration and its allies, passing new laws that restrict the presence of law enforcement at polling places or seek to thwart the federal government’s efforts to obtain sensitive election material.
Iranian Guards' business empire to win big if US sanctions lifted
Four senior Iranian sources described how the Islamic Revolutionary Guard Corps was uniquely positioned to capture a large share of any financial rewards that would accrue from sanctions relief.
Iranian Guard’s business empire to win big if U.S. sanctions lifted
As the two sides eye a deal to end the war that could unlock billions of dollars for Iran, the elite Revolutionary Guard is poised to be one of the biggest beneficiaries.
Iranian Guards' business empire to win big if U.S. sanctions lifted
Emerging outlines of a deal between Washington and Tehran to end their war contain a stinging paradox: sweeteners to coax Iran into compliance may strengthen an adversarial force that the U.S. and its Western allies consider a terrorist organisation.
Astros vs Guardians Game Discussion: 6/19/2026
Game Info Game Date/Time: Friday, June 19, 7:10 p.m. CT Location: Daikin Park, Houston, TX TV: Space City Home Network Radio: KBME 790 AM & 94.5 FM HD2; TUDN 102.9 FM HD2 (Spanish)
Brandin Podziemski details ideal Warriors pick at No. 11 in 2026 NBA Draft
Warriors guard Brandin Podziemski detailed the ideal candidate for Golden State with the No. 11 overall pick in the 2026 NBA Draft.
Tired with Iran, Trump refocuses on Ukraine
Jenna Amatulli speaks to the Guardian’s Andrew Roth about the chances this peace deal will succeed, and why Trump is turning his attention back to Ukraine
NYPD mistakes Knicks player for a fan, tries to kick him out of championship parade
Awkward. Police didn't recognize point guard Tyler Kolek at the event celebrating the New York Knicks' big win.
Brewers drop series finale to Guardians, 4-2
Bullpen squanders lead as offense fails to come through with big hit late
An emerging generation of women challenge the old guard of Sacramento politics
Cofer’s exchange with an unresponsive board exemplifies a generational shift in local politics.
A Mamdani-backed progressive’s challenge to a veteran Democrat highlights party fractures
The divides between the Democratic old guard and a new class of progressive challenger were on sharp display on Tuesday night as a congressional candidate in New York’s 13th District apologized for past disparaging remarks about Kamala Harris.
Guardian Resilience Teams promote holistic health, culture of fitness
Central to U.S. Space efforts are a transition from traditional fitness models to Holistic Health Approach, an integrated and preventative approach that prioritizes the enduring health, performance and resilience of Guardians.
Palmetto Sports Shorts: Buckner Family Legacy
WATCH: Palmetto Sports Director Carmine Gemei speaks with Clemson guard Ace Buckner about his relationship with his Tigers Hall of Fame father Greg Buckner and making his own name.
Your medical provider might be recording your mental health care visits
Mental health professionals at Kaiser are raising concerns about an artificial intelligence tool that records appointments, saying it should have more safeguards.
Jalen Brunson sends blunt Victor Wembanyama message during Knicks toast
Jalen Brunson sent a blunt message to Victor Wembanyama during the New York Knicks’ title celebrations, and the moment quickly spread across social media. Throughout the NBA Finals, the Knicks guard had steered clear of any public back-and-forth with the San Antonio Spurs star despite several flashpoints during the series.
Insider: Lakers 'widely expected' to keep Austin Reaves
According to an NBA insider, the Lakers are 'widely expected' to re-sign rising star guard Austin Reaves this summer.
Report: Nets signing away Lakers' Austin Reaves may be unlikely
The Brooklyn Nets are rumored to be one of the teams interested in Los Angeles Lakers guard Austin Reaves, but it seems like he's likely to stay put.
Spurs' Dylan Harper keeping 'positive attitude' after NBA Finals loss
Dylan Harper has separated himself as one of the best young guards in the league following his NBA Finals performance.
Brewers Make Long Awaited Call-Up
After signing a massive pre-debut contract, elite prospect Cooper Pratt heads to Milwaukee to bolster the Brewers' lineup with speed and defense against the surging Cleveland Guardians.
Seahawks rookie guard a potential impact player for 2026
Seahawks guard Beau Stephens was named by Bleacher Report as an underrated rookie that has the chance to make a big impact on the season in 2026.
The Relic: First Guardian launches July 31 for PS5 and PC, later this summer for Xbox Series and Switch 2
Dark fantasy Soulslike action RPG The Relic: First Guardian will launch for PlayStation 5 and PC via Steam on July 31, followed by Xbox Series and Switch 2l later this summer, publisher Perp Games …
Devoted dads and citizen science: The evolution of parental care in harvestmen spiders is uncovered
Citizen science data from the popular platform iNaturalist has helped uncover the evolution of parental guarding behavior in harvestmen spiders, as shown in research published in the Zoological Journal ...
Jalen Brunson seeks a role on 'SVU' after New York Knicks win historic NBA championship
Jalen Brunson is ready for his close-up: The Knicks' star point guard and captain wants to appear on 'Law & Order: SVU' after leading his team to a historic victory in the NBA championships.
Detroit Tigers series finale rained out vs Cleveland Guardians
The Detroit Tigers' game Sunday, June 14, against the Cleveland Guardians was postponed due to weather, pushing Casey Mize's return from the IL back.
The Fable 5 AI Model Just Went Dark. What the US Government’s Playbook Means for AI Companies—and Every Business Leader
Anthropic’s newest AI went dark just three days after launch. What happened next offers a stark warning for any CEO facing a powerful adversary.
Florida High School Football: Ocala Vanguard releases slate
Florida high school football schedules for the 2026 season are coming out one-by-one out of every state around the country and one region that is always a breeding ground for college prospects is over in the North Central Florida region, with a number of squads finalizing their fall slates. [ $19.99 gets you a FULL […]
Devoted dads and citizen science: the evolution of parental care in harvestmen is uncovered
Citizen science data from popular platform iNaturalist has helped uncover the evolution of parental guarding behaviour in harvestmen, as shown in research published in the Zoological Journal of the Linnean Society.
Who will the Guardians be without José Ramírez?
Hello darkness my old friend
Guardians Make Chase DeLauter Announcement After Leaving Tigers Game
The Cleveland Guardians announced an update on rookie outfielder Chase DeLauter.
Good News: NBA player connects with family of 2 young brothers facing health battles
Los Angeles Lakers guard Marcus Smart shared a moment of connection on the court with two young brothers, Kenji and Kobe, after their family was surprised with a trip to a game earlier this season. NBC News' José Díaz-Balart has more on the special moment and what Marcus is doing to raise awareness for the need for more blood stem cell donors.
Tarik Skubal pitches 4 2/3 innings during first Tigers start since elbow surgery, hits 99.9 mph in loss to Guardians
Detroit turned to Skubal for the first time since April 29, and, 38 days after his 'Skubal scope' procedure, he showed some encouraging signs.
Guardians smother Tigers in Tarik Skubal’s return
Skubal looked healthy, but Daniel Schneemann’s two-run homer was the difference.
Anna Faris credits podcast with helping her through Chris Pratt divorce
Anna Faris credited a surprising project with helping her through her 2017 divorce from Chris Pratt.
Arkansas' newest pledge Davion Thompson has elite ability
Arkansas basketball point guard commitment Davion Thompson has elite scoring ability that should serve him well as a Razorback.
Safeguarding the Beautiful Game: DisasterAWARE Powers World Cup Health Security
With more than 6.5 million fans from over 100 countries converging on cities across the United States, Mexico, and Canada for the 2026 FIFA World Cup, the public health stakes are significant. The team is leveraging DisasterAWARE for timely, integrated situational awareness...
AIPAC Wants Democrats to Back Israel. Instead, They’re Turning on AIPAC.
Once the guardian of the bipartisan pro-Israel consensus, it is now a polarizing force in the party.
Fever's Caitlin Clark, Stephanie White called for 'soft' technical vs. Sky
Indiana Fever guard Caitlin Clark was assessed her third technical of the season after arguing a no-call against the Chicago Sky.
NBA Champion Robert Horry Wants Caitlin Clark To 'Protect Herself'
Caitlin Clark received some straightforward advice from a seven-time NBA champion earlier this week. It's no secret that Clark has dealt with plenty of physicality since entering the WNBA in 2024. Roughly three weeks ago, the star guard for the Indiana Fever had a heated exchange with Golden State ...
Anthropic says 'we made the wrong tradeoff' in new model guardrails
"We're changing Fable 5's safeguards for frontier LLM development to make them visible," an Anthropic spokesperson said.
WHO urges targeted action to strengthen emergency workforce capacities for shared health risks across the Asia-Pacific region
At a time when the world is more interconnected than ever, the World Health Organization (WHO) is disseminating a comprehensive regional analysis of shared health risks across Asia and the Pacific, urging Member States to invest in enhancing workforce capacities regionwide to mitigate these risks and ensure health systems are better prepared to anticipate, tackle and withstand a range of crises and shocks. Over 100 delegates from 49 countries and areas in the Asia-Pacific region reviewed results from the regional risk analysis during the WHO-led Asia Pacific Health Security Action Framework (APHSAF) Stakeholders Meeting in Malaysia. Synthesizing insights from 21 strategic risk assessments and more than 800 multisectoral experts, the regional analysis highlighted an urgent imperative: countries must proactively invest in emergency workforce preparedness to navigate a landscape where climate hazards, disease outbreaks and geophysical events increasingly overlap. These complex converging crises create devastating, compounding impacts on health systems and communities – reiterating the need for investing in a fit-for-purpose regional health workforce and multisectoral action.Key findings: an evolving risk landscape More than half of the participating countries ranked flooding, cyclones, dengue and pandemic-potential respiratory pathogens as being of high or very high risk, while antimicrobial resistance, landslides and gastroenteritis remain widespread concerns as well. “Given that 51% – over half – of these assessed hazards are deeply interconnected, isolated health interventions are no longer sufficient,” said Dr Saia Ma’u Piukala, WHO Regional Director for the Western Pacific. “Extreme weather events like cyclones and floods directly trigger subsequent disease outbreaks, while environmental degradation – driven by sea-level rise, coastal erosion and saltwater intrusion – fuels health risks across the Pacific. Mitigating these cascading risks requires unified, cross-sectoral action linking environmental, agricultural and public health policies to build true regional resilience.” Priority recommendations for action To address critical vulnerabilities, WHO calls on Member States in the Asia-Pacific region to urgently prioritize the following strategic actions: Bridge workforce capacity gaps. Embed and standardize emergency preparedness within academia to promote regional workforce interoperability. Foster multisectoral coordination. Address ad-hoc taskforce responses and fragmented surge support through formalized contingency plans and standard operating procedures that are frequently updated and tested. Secure sustainable financing for emergencies. Overcome systemic barriers to access dedicated funding for both immediate anticipatory actions and long-term emergency preparedness initiatives. Enable emergency-ready primary health care. Embed emergency management into public health workforce readiness planning. Ensure that emergency planning is inclusive. Establish clear pathways for inclusive emergency planning that actively involves communities most at risk and other vulnerable groups. Optimize communication. Update risk communication and community engagement strategies, aligning them with seasonal risk calendars. Elevating workforce readiness to meet regional health risks While the gaps identified are significant, the Asia-Pacific region possesses solid foundational pillars, including dedicated clinicians, laboratory staff, rapid response teams, emergency medical teams and extensive community networks. However, to adequately address the compounding nature of modern crises, the various components of the emergency workforce must collaborate cohesively. True resilience depends entirely on transforming this currently fragmented workforce into a highly trained, interconnected and rapidly deployable asset. To achieve this, WHO is actively advancing regional workforce capacities through the Global Health Emergency Corps initiative. This initiative – supported by the Gates Foundation and the Institute of Philanthropy – seeks to build a seamless network of emergency workforce across borders and sectors, ensuring that when a crisis strikes, a standardized, well-coordinated and trained workforce is immediately ready to respond. “Scaling up emergency workforce readiness is no longer optional,” said Dr Gina Samaan, Regional Emergency Director for WHO in the Western Pacific. “It is the definitive factor that will determine how effectively the Asia-Pacific region safeguards health and protects lives in an increasingly unpredictable future.” ____________________For more information, or to arrange media interviews, contact: Ara Johannes, WHO Western Pacific Health Emergencies Division: johannesa@who.int WHO Western Pacific Communications: wprocom@who.int
New York Yankees @ Cleveland Guardians: Carlos Rodón vs. Parker Messick
It’s a southpaw showdown as the Yankees go for the sweep.